NLBNPIT1VHN5 20351221 19.4331 News - P1VHN5

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

New Data Presented at Heart Rhythm Society Conference Demonstrates Continued Progress with Company’s AI Program Data Show That Applying AI to VCG...

HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program

Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies HeartBeam...

HeartBeam Reports First Quarter 2024 Results

Continued Clinical and Regulatory Progress on the AIMIGo™ 3D VECG System Presented Positive Results on its Artificial Intelligence Capabilities...

HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights...

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

New Data Presented at the European Heart Rhythm Association Conference Marks First Scientific Presentation on HeartBeam AI, the Company’s Deep...

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing Clinical and Regulatory Progress for...

First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG

VALID-ECG Study will Form the Basis of the Company’s Upcoming FDA 510(k) Submission HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company...

HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology

Company Continues Expanding its Intellectual Property Footprint, Now has 14 US and 4 International Patents HeartBeam, Inc. (NASDAQ: BEAT), a...

HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights...

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

Company Appoints Mohammad Shokoohi-Yekta to Lead Program and Industry Pioneer Lance Myers as Advisor HeartBeam, Inc. (NASDAQ: BEAT), a medical...

HeartBeam Reports Third Quarter 2023 Financial Results

Strengthens Leadership with Appointments to Executive Team and Boards Publishes Landmark Peer-Reviewed Article, Validating Technology Ongoing...

HeartBeam Announces Expansion of Its Scientific Advisory Board

Company Adds Leading Cardiologists to Provide Strategic Insights HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed...

HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias

New Patent Extends Intellectual Property Footprint for Company’s Groundbreaking Technology in Large ECG Patch Monitor Market HeartBeam, Inc...

HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time

HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only credit card-size 3D-vector electrocardiogram...

Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer

Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer PR Newswire CAMBRIDGE, Mass...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

NLBNPIT1VHN5 20351221 19.4331 (P1VHN5)

Professional-Grade Tools, for Individual Investors.

P1VHN5 News

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program

HeartBeam Reports First Quarter 2024 Results

HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG

HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology

HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

HeartBeam Reports Third Quarter 2023 Financial Results

HeartBeam Announces Expansion of Its Scientific Advisory Board

HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias

HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time

Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer

P1VHN5 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

NLBNPIT1VHN5 20351221 19.4331 (P1VHN5) News

NLBNPIT1VHN5 20351221 19.4331 (P1VHN5)

Professional-Grade Tools, for Individual Investors.

P1VHN5 News

HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program

HeartBeam Reports First Quarter 2024 Results

HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time

HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG

HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology

HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

HeartBeam Reports Third Quarter 2023 Financial Results

HeartBeam Announces Expansion of Its Scientific Advisory Board

HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias

HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time

Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer

P1VHN5 Discussion

Your Recent History